Who are the key players in North America Biologics Safety Testing Market industry?

The top 5 players in the North America Biologics Safety Testing Market are Thermo Fisher Scientific, Charles River Laboratories, Merck KGaA, Lonza Group, and Eurofins Scientific. These companies lead in offering advanced biologics safety solutions, extensive testing portfolios, global presence, and continuous R&D investments to address evolving regulatory and quality requirements.

What is the North America Biologics Safety Testing Market growth?

The North America Biologics Safety Testing Market is experiencing robust growth, driven by increased biologic drug development and frequent FDA approvals. For example, Thermo Fisher Scientific has expanded its biological testing services with innovative assay technologies, fueling significant sector growth and enhancing safety assurance across biopharmaceutical manufacturing in the region.

Which segment accounted for the largest North America Biologics Safety Testing Market share?

The largest market share belongs to the vaccines & therapeutics application segment. This is due to heightened demand for vaccine safety post-COVID-19, and regulatory pressure for stringent safety verification in new biologics. Increasing biopharmaceutical investment has propelled testing requirements for both established and novel therapies across North America.

What are the factors driving the North America Biologics Safety Testing Market?

Stringent regulatory frameworks and rising incidence of chronic diseases drive market growth. Companies like Merck KGaA have launched advanced safety testing kits in response to tightened FDA guidelines, ensuring compliance and safeguarding public health, further accelerating market expansion and adoption of novel biologics testing solutions.

Which type accounted for the largest North America Biologics Safety Testing Market share?

Endotoxin tests account for the largest market share among biologics safety testing types. Their critical role in detecting pyrogenic contaminants in medical products is indispensable for patient safety. Leading providers like Charles River Laboratories offer comprehensive endotoxin detection solutions, emphasizing reliability and accuracy across biopharmaceutical quality control.

Home Healthcare

North America Biologics Safety Testing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Biologics Safety Testing Market: by Type (Kits & Reagents, Services, Instruments), Application (Vaccines & Therapeutics, Blood Products, Cellular & Gene Therapy, Tissue & Tissue Products, Stem Cell Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Retail Pharmacies, Hospitals, Others), Technology (PCR, ELISA, Cell Culture, High-Throughput Sequencing, Immunoassays, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20386

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	2150
Regions	US, Canada, Mexico
Segments	By Type: Kits & Reagents, Services, Instruments, Consumables, Software, Others; By Application: Vaccines & Therapeutics, Blood Products, Cellular & Gene Therapy, Tissue & Tissue Products, Stem Cell Products, Others; By Distribution Channels: Direct Sales, Distributors, Online Sales, Retail Pharmacies, Hospitals, Others; By Technology: PCR, ELISA, Cell Culture, High-Throughput Sequencing, Immunoassays, Others; By Organization Size: Small, Medium, Large
Players	Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Eurofins Scientific, SGS SA, Lonza Group, Sartorius AG, WuXi AppTec, Promega Corporation, Toxikon Corporation, Danaher Corporation, Bio-Rad Laboratories, GenScript Biotech Corporation, Fujifilm Diosynth Biotechnologies, Avance Biosciences

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Study period:

2020-2035

Base year:

2026

Historical data

2020-2024

NO OF PAGE:

167

Customize This Report to Suit Your Requirements

Name

Bussiness Email

country

Phone number

Consulting Service

How Will You Befit From our consulting service

Get in touch with Us

US +91 89837 31618 (Tool Free)

sales [at] bussinessinsights.com

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	2150
Regions	US, Canada, Mexico
Segments	By Type: Kits & Reagents, Services, Instruments, Consumables, Software, Others; By Application: Vaccines & Therapeutics, Blood Products, Cellular & Gene Therapy, Tissue & Tissue Products, Stem Cell Products, Others; By Distribution Channels: Direct Sales, Distributors, Online Sales, Retail Pharmacies, Hospitals, Others; By Technology: PCR, ELISA, Cell Culture, High-Throughput Sequencing, Immunoassays, Others; By Organization Size: Small, Medium, Large
Players	Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Eurofins Scientific, SGS SA, Lonza Group, Sartorius AG, WuXi AppTec, Promega Corporation, Toxikon Corporation, Danaher Corporation, Bio-Rad Laboratories, GenScript Biotech Corporation, Fujifilm Diosynth Biotechnologies, Avance Biosciences